您的购物车当前为空
Firuglipel is an orally available and selective agonist of GPR119.

Firuglipel is an orally available and selective agonist of GPR119.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 25 mg | ¥ 12,800 | 8-10周 | |
| 50 mg | ¥ 16,800 | 8-10周 | |
| 100 mg | ¥ 21,500 | 8-10周 |
Firuglipel 相关产品
| 产品描述 | Firuglipel is an orally available and selective agonist of GPR119. |
| 体外活性 | Firuglipel increases intracellular cAMP in a concentration-dependent manner in rat, human, and mouse GPR119-expressing Chinese hamster ovary (CHO)-K1 cells (EC50: 51.5, 98.4, and 108.1 nM, respectively). Firuglipel has no effect on intracellular cAMP in pcDNA3.1/CHO-K1 cells. |
| 体内活性 | Firuglipel (1-30 mg/kg) upregulates glucagon-like peptide-1. It also enhances glucose-dependent insulin secretion and improves glucose homeostasis in type 2 diabetic rats. |
| 分子量 | 467.49 |
| 分子式 | C25H26FN3O5 |
| CAS No. | 1371591-51-3 |
| 密度 | 1.31g/cm3 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容